IJCRR - 8(16), August, 2016
HEPATOCELLULAR CARCINOMA TREATMENT; NONSURGICAL APPROACHES
Author: Mohammed Alnaggar
Primary liver cancer (PLC) is one of the common cancers with high incidence and poor prognosis. PLC has become one of the major diseases that causes serious harm to human health and life. In recent years, domestic and foreign researchers have studied and summarized the current status of primary liver cancer treatment, and have made great progress as well. Significant progress in terms of early diagnosis, surgical treatment, and comprehensive treatment of liver cancer results in improvement in patient’s quality of life. So far, there are many available methods that can be used to improve the quality of life in these patients, but still there are many issues that need to be addressed intensively. The progress in the study of liver cancer may bring about a new hope for the treatment of liver cancer.
Non-surgical treatment plays an important role in the treatment of primary liver cancer, which includes transcatheter arterial chemoembolization, percutaneous ablation therapy, radiation therapy, chemotherapy, etc
Keywords: Primary liver cancer; Non-surgical treatments progress, Quality of life
Mohammed Alnaggar. HEPATOCELLULAR CARCINOMA TREATMENT; NONSURGICAL APPROACHES International Journal of Current Research and Review. 8(16), August, 01-04
1. Sala M, Llovet J M, Vilana R, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma [J]. Hepatology, 2004, 40(6): 1352-1360.
2. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation[J]. RadiologyRadiological Society of North America, 2005, 234(3): 961-967.
3. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma[J]. Cancer, 2005, 103(6): 1201-1209.
4. Omata M, Tateishi R, Yoshida H, et al. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation[J]. Gastroenterology, 2004, 127(5): S159-S166.
5. Teratani T, Ishikawa T, Shiratori Y, et al. Hepatocellular carcinoma in elderly patients[J]. Cancer, 2002, 95(4): 816-823.
6. Kurokohchi K, Hosomi N, Yoshitake A, et al. Successful treatment of large-size advanced hepatocellular carcinoma by transarterial chemoembolization followed by the combination therapy of percutaneous ethanol-lipiodol injection and radiofrequency ablation[J]. Oncology reports, 2006, 16(5): 1067-1070.
7. Okano H, Shiraki K, Inoue H, et al. Combining transcatheter arterial chemoembolization with percutaneous ethanol injection therapy for small size hepatocellular carcinoma[J]. International journal of oncology, 2001, 19(5): 909-912.
8. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma[J]. Gastroenterology, 2005, 129(1): 122- 130.
9. Lin S M, Lin C J, Lin C C, et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma≤ 4 cm[J]. Gastroenterology, 2004, 127(6): 1714-1723.
10. Uehara T, Hirooka M, Ishida K, et al. Percutaneous ultrasoundguided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites[J]. Journal of gastroenterology, 2007, 42(4): 306-311.
11. Seror O, N’kontchou G, Tin Tin Htar M, et al. Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis: A retrospective study of efficacy and cost[J]. Gastroentérologie clinique et biologique, 2006, 30(11): 1265-1273.
12. Ferrari F S, Megliola A, Scorzelli A, et al. Treatment of small HCC through radiofrequency ablation and laser ablation. Comparison of techniques and long-term results[J]. La radiologia medica, 2007, 112(3): 377-393.
13. Shibata T, Iimuro Y, Yamamoto Y, et al. Small hepatocellular carcinoma: comparison of radiofrequency ablation and percutaneous microwave coagulation therapy[J]. RADIOLOGY-OAK BROOK IL-, 2002, 223(2): 331-338.
14. Seki S, Sakaguchi H, Iwai S, et al. Five-year survival of patients with hepatocellular carcinoma treated with laparoscopic microwave coagulation therapy[J]. Endoscopy, 2005, 37(12): 1220- 1225.
15. Goldstein H M, Wallace S, Anderson J H, et al. Transcatheter Occlusion of Abdominal Tumors 1[J]. Radiology, 1976, 120(3): 539-545.
16. Vogl T J, Naguib N N N, Nour-Eldin N E A, et al. Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications[J]. European journal of radiology, 2009, 72(3): 505- 516.
17. Liu M T, Li S H, Chu T C, et al. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization[J]. Japanese journal of clinical oncology, 2004, 34(9): 532-539.
18. Tatsumi T, Takehara T, Kanto T, et al. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma [J]. Cancer research, 2001, 61(20): 7563-7567.
19. Peng B G, Liang L J, He Q, et al. Tumor vaccine against recurrence of hepatocellular carcinoma[J]. World J Gastroenterology, 2005, 11(5): 700-704.